These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8097921)

  • 1. Human studies on abecarnil a new beta-carboline anxiolytic: safety, tolerability and preliminary pharmacological profile.
    Duka T; Schütt B; Krause W; Dorow R; McDonald S; Fichte K
    Br J Clin Pharmacol; 1993 Apr; 35(4):386-94. PubMed ID: 8097921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and acute toleration of the beta-carboline derivative abecarnil in man.
    Krause W; Schütt B; Duka T
    Arzneimittelforschung; 1990 May; 40(5):529-32. PubMed ID: 1974428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
    Löscher W; Hönack D; Scherkl R; Hashem A; Frey HH
    J Pharmacol Exp Ther; 1990 Nov; 255(2):541-8. PubMed ID: 1978730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.
    Mumford GK; Rush CR; Griffiths RR
    J Pharmacol Exp Ther; 1995 Feb; 272(2):570-80. PubMed ID: 7853170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychomotor effects of the anxiolytic abecarnil: a comparison with lorazepam.
    Hege SG; Ellinwood EH; Wilson WH; Helligers CA; Graham SM
    Psychopharmacology (Berl); 1997 May; 131(2):101-7. PubMed ID: 9201796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of gamma-aminobutyric acidA receptor complex after the in vivo administration of the anxioselective and anticonvulsant beta-carboline derivative abecarnil.
    Serra M; Foddi MC; Ghiani CA; Melis MA; Motzo C; Concas A; Sanna E; Biggio G
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1360-8. PubMed ID: 1361574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio.
    Turski L; Stephens DN; Jensen LH; Petersen EN; Meldrum BS; Patel S; Hansen JB; Löscher W; Schneider HH; Schmiechen R
    J Pharmacol Exp Ther; 1990 Apr; 253(1):344-52. PubMed ID: 1970362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors.
    Stephens DN; Schneider HH; Kehr W; Andrews JS; Rettig KJ; Turski L; Schmiechen R; Turner JD; Jensen LH; Petersen EN
    J Pharmacol Exp Ther; 1990 Apr; 253(1):334-43. PubMed ID: 1970361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abecarnil, a beta-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal effects in mice.
    Natolino F; Zanotti A; Contarino A; Lipartiti M; Giusti P
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):612-7. PubMed ID: 8938660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single dose efficacy evaluation of two partial benzodiazepine receptor agonists in photosensitive epilepsy patients: A placebo-controlled pilot study.
    Kasteleijn-Nolst Trenité DG; Groenwold RH; Schmidt B; Löscher W
    Epilepsy Res; 2016 May; 122():30-6. PubMed ID: 26921854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of the novel anxiolytic beta-carboline abecarnil in rodents and primates.
    Ozawa M; Nakada Y; Sugimachi K; Yabuuchi F; Akai T; Mizuta E; Kuno S; Yamaguchi M
    Jpn J Pharmacol; 1994 Mar; 64(3):179-87. PubMed ID: 7912751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment with abecarnil does not induce diazepam-like dependence in mice.
    Steppuhn KG; Schneider HH; Turski L; Stephens DN
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1395-400. PubMed ID: 8095551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abecarnil, a new beta-carboline, in the treatment of anxiety disorders.
    Aufdembrinke B
    Br J Psychiatry Suppl; 1998; (34):55-63. PubMed ID: 9829018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of basal and stress-induced release of acetylcholine and dopamine in rat brain by abecarnil and imidazenil, two anxioselective gamma-aminobutyric acidA receptor modulators.
    Dazzi L; Motzo C; Imperato A; Serra M; Gessa GL; Biggio G
    J Pharmacol Exp Ther; 1995 Apr; 273(1):241-7. PubMed ID: 7714771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic pharmacological activities of the novel anxiolytic beta-carboline abecarnil in rats.
    Ozawa M; Sugimachi K; Nakada-Kometani Y; Akai T; Yamaguchi M
    J Pharmacol Exp Ther; 1994 May; 269(2):457-62. PubMed ID: 7910208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of the anxiolytic beta-carboline derivative abecarnil in the mouse, rat, rabbit, dog, cynomolgus monkey and baboon. Studies on species differences.
    Krause W; Mengel H
    Arzneimittelforschung; 1990 May; 40(5):522-9. PubMed ID: 1974427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental transfer of the anxiolytic beta-carboline abecarnil in rabbit.
    Krause W; Mechelke B
    Arzneimittelforschung; 1992 Sep; 42(9):1079-82. PubMed ID: 1359894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and safety of deramciclane during multiple oral dosing.
    Kanerva H; Kilkku O; Helminen A; Rouru J; Scheinin M; Huupponen R; Klebovich I; Drabant S; Urtti A
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):589-97. PubMed ID: 10599951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.